Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women

[1]  Javier Benítez,et al.  Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes , 2009, Breast Cancer Research.

[2]  C. Parise,et al.  Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999–2004 , 2009, The breast journal.

[3]  P. Rosenberg,et al.  Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. , 2009, Journal of the National Cancer Institute.

[4]  Dawn L Hershman,et al.  Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. , 2009, Journal of the National Cancer Institute.

[5]  R. Coates,et al.  The epidemiology of triple-negative breast cancer, including race , 2009, Cancer Causes & Control.

[6]  R. Stephens,et al.  Differences in the Tumor Microenvironment between African-American and European-American Breast Cancer Patients , 2009, PloS one.

[7]  Wonshik Han,et al.  CAMK1D amplification implicated in epithelial–mesenchymal transition in basal‐like breast cancer , 2008, Molecular oncology.

[8]  C I Li,et al.  Differential patterns of allelic loss in estrogen receptor‐positive infiltrating lobular and ductal breast cancer , 2008, Genes, chromosomes & cancer.

[9]  W. Grady,et al.  Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.

[10]  J. Peterse,et al.  Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH , 2008, Breast Cancer Research and Treatment.

[11]  O. Brawley,et al.  High prevalence of triple‐negative tumors in an urban cancer center , 2008, Cancer.

[12]  Wonshik Han,et al.  DNA copy number alterations and expression of relevant genes in triple‐negative breast cancer , 2008, Genes, chromosomes & cancer.

[13]  Samuel Leung,et al.  Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype , 2008, Clinical Cancer Research.

[14]  R. Coates,et al.  Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA , 2008, Breast Cancer Research and Treatment.

[15]  R. Tibshirani,et al.  Spatial smoothing and hot spot detection for CGH data using the fused lasso. , 2008, Biostatistics.

[16]  Daniel Birnbaum,et al.  Integrated profiling of basal and luminal breast cancers. , 2007, Cancer research.

[17]  N. Sneige,et al.  Triple Negative Breast Carcinoma and the Basal Phenotype: From Expression Profiling to Clinical Practice , 2007, Advances in anatomic pathology.

[18]  Johan Staaf,et al.  BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm359 Data and text mining , 2022 .

[19]  F. Kittrell,et al.  Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34. , 2007, Cancer research.

[20]  R. Cress,et al.  Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.

[21]  M. Schindl,et al.  Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. , 2007, Anticancer research.

[22]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[23]  Robert Tibshirani,et al.  Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer , 2006, Genes, chromosomes & cancer.

[24]  D. Birnbaum,et al.  BMC Cancer , 2003 .

[25]  C. Ambrosone,et al.  Breast cancer in African-American women: differences in tumor biology from European-American women. , 2006, Cancer research.

[26]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[27]  Ajay N. Jain,et al.  Breast tumor copy number aberration phenotypes and genomic instability , 2006, BMC Cancer.

[28]  G. Colditz,et al.  Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  D. Louis,et al.  A pseudolikelihood approach for simultaneous analysis of array comparative genomic hybridizations. , 2005, Biostatistics.

[30]  Zhao Chen,et al.  Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.

[31]  G. Ball,et al.  High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.

[32]  Douglas Grove,et al.  Denoising array-based comparative genomic hybridization data using wavelets. , 2005, Biostatistics.

[33]  Barbara J. Trask,et al.  Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes , 2004, Cancer Research.

[34]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[35]  Puay Hoon Tan,et al.  Conservation of Breast Cancer Molecular Subtypes and Transcriptional Patterns of Tumor Progression Across Distinct Ethnic Populations , 2004, Clinical Cancer Research.

[36]  R. Coates,et al.  Racial differences in the expression of cell cycle–regulatory proteins in breast carcinoma , 2004, Cancer.

[37]  I. Ellis,et al.  Expression of luminal and basal cytokeratins in human breast carcinoma , 2004, The Journal of pathology.

[38]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[39]  J. Stanford,et al.  Breastfeeding and breast cancer risk , 1995, Cancer Causes & Control.

[40]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  V. Shavers,et al.  Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 , 2003, Cancer.

[42]  Marcel J T Reinders,et al.  Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. , 2002, Cancer research.

[43]  Samuel S. Wu,et al.  A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays. , 2001, Physiological genomics.

[44]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  David Botstein,et al.  Promoter-specific binding of Rap1 revealed by genome-wide maps of protein–DNA association , 2001, Nature Genetics.

[46]  B. Trock,et al.  C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance , 2000, British Journal of Cancer.

[47]  P. Rabinovitch,et al.  Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis. , 1996, Cytometry.

[48]  S. Joslyn.  Racial differences in survival from breast cancer. , 1995, JAMA.

[49]  C K Redmond,et al.  Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. , 1994, JAMA.

[50]  Robert Clarke,et al.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.

[51]  H. Dayal,et al.  Race and socio-economic status in survival from breast cancer. , 1982, Journal of chronic diseases.